Search - tctmd.com

Displaying 1 - 4 of 4

Sort: Relevancy | Date

NOACs Significantly Curb Risk of VTE in Cancer Patients

News Daily News

NOACs Significantly Curb Risk of VTE in Cancer Patients

December 06, 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

August 26, 2018

How to Interpret Hypercoagulable Laboratory Results while your patient is on one of the NOACs

Presentation VEINS 2014

How to Interpret Hypercoagulable Laboratory Results while your patient is on one of the NOACs

Presenter: John R. Bartholomew

October 10, 2014

Prophylaxis and Medical Management of Venous Disease: Monitoring and Reversing NOACs

Presentation VEINS 2014

Prophylaxis and Medical Management of Venous Disease: Monitoring and Reversing NOACs

Presenter: James B. Froehlich

October 10, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.